Monro (MNRO) stock is currently trading near its 52-week low at $19.60, reflecting a 21% decline over the past month due to disappointing Q3 results and lack of FY25 guidance. Bulls may view the stock as oversold, with an RSI of 16.8 indicating potential for a rebound, especially if operational improvements materialize. However, macroeconomic headwinds and weak financial performance suggest limited near-term upside, with Wells Fargo recently lowering its price target to $20.